Patent 11077103 was granted and assigned to Aurobindo Pharma on August, 2021 by the United States Patent and Trademark Office.
The present invention relates to solid dispersion of Naloxegol oxalate. Further, the present invention relates to an improved process for Naloxegol oxalate and intermediates thereof.